Company: CNTB
Filing Date: 2025-06-10
Form Type: F-3
Source: 0001193125-25-138482
Chunk: 69

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-06-10
Form: F-3
Chunk 69
---
 Market (“Nasdaq”), on or through
any other existing trading market for our Ordinary Shares or ADSs or to or through a market maker. If expressly authorized by us, the Sales Agent may also sell the ADSs in privately negotiated transactions. The Sales Agent is not required to sell
any specific number or dollar amount of securities but will act as our sales agent using commercially reasonable efforts consistent with their normal trading and sales practices and applicable state and federal laws, rules and regulations and the
rules of the Nasdaq, on mutually agreed terms between the Sales Agent and us. There are no minimum sale requirements, and there is no arrangement for funds to be received in any escrow, trust or similar arrangement.

The compensation payable to the Sales Agent for sales of ADSs sold pursuant to the Sales Agreement will be an amount up to
3.0% of the gross proceeds of any ADSs sold under the Sales Agreement. See “Plan of Distribution” beginning on page 46 for additional information regarding the compensation to be paid to the Sales Agent. In connection with the sale
of the ADSs on our behalf, the Sales Agent will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation paid to the Sales Agent will be deemed to be underwriting compensation. We have also agreed in
the Sales Agreement to provide indemnification and contribution to the Sales Agent with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The ADSs are listed on the Nasdaq under the symbol “CNTB.” On June 9, 2025, the last reported sale price
of the ADSs on the Nasdaq was $0.78 per ADS.

Our principal executive offices are located at 3580 Carmel Mountain Road,
Suite 200, San Diego, California 92130, and our telephone number is +1 858 727 1040. Our registered office in the Cayman Islands is located at the offices of Maples Corporate Services Limited at PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.

As of June 9, 2025, the aggregate market value of our
outstanding ADSs held by non-affiliates, or public float, was approximately $35,102,960.85, based on 55,561,056 shares of outstanding ADSs, of which 14,263,455 shares were